Background: Atherosclerosis is a metabolic disorder characterized by hyperlipidemia and chronic inflammation that is initiated by endothelial dysfunction and altered lipid homeostasis. Sigma1 receptor (Sigmar1) is a ubiquitously expressed chaperone protein known to have a role in lipid metabolism and ER-mitochondrial lipid transport. Although studies showed a correlation between Sigmar1 inhibition and induction of inflammation, the role of Sigmar1 in regulating vascular inflammation during atherosclerosis remained unknown. Hypothesis: Absence of Sigmar1 will accelerate the development and progression of atherosclerosis by inducing endothelial inflammation and mitochondrial dysfunction. Methods and Results: We used a hypercholesterolemia model induced by AAV8-PCSK9 injection followed by 12 weeks of western diet (WD) in wildtype (Wt) and global Sigmar1 knockout (Sigmar1 -/- ) mice to determine the role of Sigmar1 in diet-induced atherosclerosis. We also used human aortic endothelial cells (HAEC) and CRISPR-Cas9 mediated Sigmar1 knockout HAECs (HAEC hKO ) to delineate the molecular mechanisms in vitro . Sigmar1 protein level was notably decreased in the human and mouse atherosclerotic tissues and in HAECs treated with inflammatory trigger, LPS+IFNγ. We observed increased atherosclerotic plaque area in aorta by en face analysis in Sigmar1 -/- mice compared to Wt mice subjected to PCSK9/WD model. LPS+IFNγ treated HAEC hKO showed significant upregulation of EC adhesion molecules (VCAM1, ICAM1) and activated nuclear factor NFκB expressions than the control HAEC hWT . Since mitochondrial dysfunction and elevated reactive oxygen species (ROS) generation play a role in inflammation and diseases, and Sigmar1 is known to regulate mitochondrial function, we wanted to dissect the contribution of EC-Sigmar1 in vascular inflammation. Both lack of Sigmar1 and LPS+IFNγ stimuli significantly reduced mitochondrial respiration in HAEC hKO cells and induced ROS production along with the induction of inflammation. Conclusion: So, lack of Sigmar1 leads to increased atherosclerotic plaque area in mice in response to PCSK9/WD suggesting a novel protective role for Sigmar1 in the development and progression of atherosclerosis and vascular inflammation.
No takes yet. Share an insight, caveat, or question.
Remex et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: